Navigation Links
Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
Date:6/18/2010

Net revenue in the first quarter of 2010 increased 25.6% to RMB 113.3 million ($16.6 million) from RMB 90.2 million in the first quarter of 2009. Xianling Gubao ("XLGB") sales were RMB 54.5 million ($8.0 million) in the first quarter of 2010, compared to RMB 54.8 million in the first quarter of 2009. Net revenue from Moisturizing & Anti-itching Capsules and Zaoren Anshen Capsules reached RMB 14.7 million ($2.2 million) in the first quarter of 2010, compared to RMB 15.0 million in the first quarter of 2009. Net revenue from the Company's other products increased 116.2% to RMB 44.1 million ($6.4 million) from RMB 20.4 million in the first quarter of 2009. Revenue contribution from Anhui Jingfang Pharmaceutical Co., Ltd. ("Jingfang"), which was acquired at the end of the first quarter of 2009, was RMB 18.8 million ($2.8 million), compared to RMB14.0 million in the fourth quarter of 2009.

Gross profit increased 18.7% to RMB 62.3 million ($9.1 million) in the first quarter of 2010 from RMB 52.5 million in the first quarter of 2009. Gross margin was 55.0% in the first quarter of 2010, compared to 58.2% in the same period of 2009. Tongjitang's gross margin reflects higher revenue contribution from lower-margin products, as well as increased costs of raw materials, other than barrenwort, related to herbal medicines. Market price of barrenwort has remained relatively stable and we have maintain
'/>"/>

SOURCE Tongjitang Chinese Medicines Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
2. Biosites Triage Products Seized by Beijing Customs; Chinese Market Facing Shortage
3. China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology
4. Chinese Distribution Contract Extended for an Additional 4 Years
5. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
6. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
7. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
8. Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World
9. GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
10. Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy
11. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... ALISO VIEJO, Calif. , Dec. 22, 2014 /PRNewswire/ ... moved into expanded corporate offices in Aliso ... President, announced that due to the tremendous growth and ... critically needed. Sales of patented SnoreRx, the anti snore ... administrative offices. He said, "We are now in ...
(Date:12/22/2014)...   TRU-D SmartUVC LLC, producers of the ... today that the General Services Administration has awarded the ... This newly formed agreement will allow TRU-D ... purchasers, including Department of Veteran Affairs and Department of ... purchasing solutions for the Ebola effort in ...
(Date:12/22/2014)...  ConvaTec, a privately-held medical products and technologies company, ... Chief Executive Officer of the company, effective December 22, ... .  "The Board of Directors of ConvaTec thanks Mr. ... past three years," said Magnus Lundberg , the ... that the company is well positioned for the future."  ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... 1, 2011 Reportlinker.com announces that a ... its catalogue: Cancer ... Forecasts to 2017 ... Therapeutics - Pipeline Assessment and Market Forecasts ...
... YORK, June 1, 2011 Reportlinker.com announces that ... its catalogue: China,s Guidebook for ... China,s-Guidebook-for-Pharmaceutical-Patent-Protection.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication Description China ... market in the world by 2010 with a ...
Cached Medicine Technology:Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017 10Reportlinker Adds China's Guidebook for Pharmaceutical Patent Protection 2Reportlinker Adds China's Guidebook for Pharmaceutical Patent Protection 3Reportlinker Adds China's Guidebook for Pharmaceutical Patent Protection 4Reportlinker Adds China's Guidebook for Pharmaceutical Patent Protection 5Reportlinker Adds China's Guidebook for Pharmaceutical Patent Protection 6
(Date:12/25/2014)... The microscopy market is estimated to ... $5,756.0 million by 2019. Optical microscopy is the ... microscopes product segment is expected to show the ... focus on nanotechnology, technological advancements, and increasing federal ... , Get Full Copy of Report @ ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... 25, 2014 The short film “Color of ... in honor of a true 9/11 hero, Welles Remy Crowther. ... including the 24 hours of Nuremberg International Short Film Festival ... , Actress, screenwriter and director Luciana Lagana plays ... together with her husband, Gregory Graham - Graham ...
(Date:12/25/2014)... 2014 Helen Harris’ RP (Retinitis Pigmentosa) ... California after an 8 year battle with breast cancer. ... evening in her home in Woodland Hills California after ... , As the founder and volunteer ... pioneered and championed many of today's greatest breakthroughs in ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... , WEDNESDAY, Feb. 1 (HealthDay News) -- Child abuse and ... is comparable to the costs of other major public health ... U.S. Centers for Disease Control and Prevention analyzed 1,740 fatal ... of one year. The investigators found that the lifetime ...
... Ore. Researchers have developed a type of wearable, non-invasive ... rate and respiration at the same time it records a ... and patient care. The device is just two inches ... with the skin and can operate for a week without ...
... , WEDNESDAY, Feb. 1 (HealthDay News) -- About one ... the United States by Pfizer Inc. because of a packaging ... cause unintended pregnancies. The recall of 14 lots of ... Estradiol tablets was announced late Tuesday after Pfizer discovered that ...
... WEDNESDAY, Feb. 1 (HealthDay News) -- Many adults whose parents ... brain aging in middle age that may precede a stroke, ... with an average age of 61 who underwent MRI brain ... the volume of white matter lesions and other signs of ...
... ) publishes online and in print today a ... form cutting-edge genomic and epigenomic analyses of cancer. ... biological insights gained from genomic analyses of pancreatic ... analyses of breast cancer genes, large scale colorectal ...
... that can cause inflammation and organ failure, has different ... why some people are very susceptible to the infection, ... they could study liver cells from different people in ... these varying responses. However, liver cells are difficult to ...
Cached Medicine News:Health News:Child Abuse, Neglect a Major Public Health Problem: CDC 2Health News:Pfizer Recalls 1 Million Packets of Birth Control Pills 2Health News:Adult Children of Stroke Sufferers May Show Signs of Brain Aging, Too 2Health News:Genome Research publishes special issue: Cancer Genomics 2Health News:Genome Research publishes special issue: Cancer Genomics 3Health News:Genome Research publishes special issue: Cancer Genomics 4Health News:Genome Research publishes special issue: Cancer Genomics 5Health News:Genome Research publishes special issue: Cancer Genomics 6Health News:Genome Research publishes special issue: Cancer Genomics 7Health News:MIT: Stem cells could drive hepatitis research forward 2Health News:MIT: Stem cells could drive hepatitis research forward 3
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
The Uro San® Plus male external catheter is a latex catheter with a double-sided adhesive and Shield Skin Protective Dressing....
... Pak Seven Starter Kit: a ... of Freedom Clear catheters and ... 100% latex-free along with ... convenience and comfort. Plus each ...
Medicine Products: